维生素D治疗腹泻型肠易激综合征的研究进展
Vitamin D in the Treatment of Diarrhea Type Irritable Bowel Syndrome
DOI: 10.12677/ACM.2023.13122893, PDF,   
作者: 高溪媛, 黄志龙：新疆医科大学第四临床医学院，新疆 乌鲁木齐；苏莎莎*：新疆医科大学附属中医医院脾胃科，新疆 乌鲁木齐
关键词: 肠易激综合征；腹泻型；维生素D；药物治疗；Irritable Bowel Syndrome； Diarrhea Type； Vitamin D； Drug Therapy
摘要: 随着社会日益发展、环境不断变化及心理压力的增大，肠易激综合征(Irritable bowel syndrome, IBS)在我国人群患病率呈逐渐升高趋势，因其发病机制较为复杂，目前尚无特效治疗方法；维生素Ｄ是一种常见的脂溶性维生素。研究发现，维生素D对缓解腹泻型肠易激综合征(IBS-D)的病情程度和改善患者生活质量具有一定的作用。本文对维生素D与IBS-D相关性的研究进展以及维生素D治疗IBS-D的疗效和作用机制作一综述，希望能为IBS-D的临床诊治提供新思路。
Abstract: With the increasing development of society, changing environment, and increasing psychological pressure, the incidence of Irritable Bowel Syndrome (IBS) in the Chinese population is gradually increasing. Due to its complex pathogenesis, there is currently no specific treatment method. Vita-min D is a common fat-soluble vitamin. Research has found that vitamin D has a certain effect on al-leviating the severity of diarrhea induced irritable bowel syndrome (IBS-D) and improving the quality of life of patients. This article provides a review of the research progress on the correlation between vitamin D and IBS-D, as well as the efficacy and mechanism of vitamin D in the treatment of IBS-D. It is hoped to provide new ideas for the clinical diagnosis and treatment of IBS-D.
文章引用：高溪媛, 黄志龙, 苏莎莎. 维生素D治疗腹泻型肠易激综合征的研究进展[J]. 临床医学进展, 2023, 13(12): 20572-20577. https://doi.org/10.12677/ACM.2023.13122893

参考文献

[1] 中华医学会消化病学分会胃肠功能性疾病协作组, 中华医学会消化病学分会胃肠动力学组. 2020年中国肠易激综合征专家共识意见[J]. 中华消化杂志, 2020, 40(12): 803-818.
[2] Liu, Y.L. and Liu, J.S. (2021) Irritable Bowel Syndrome in China: A Review on the Epidemiology, Diagnosis, and Management. Chinese Medical Journal, 134, 1396-1401. [Google Scholar] [CrossRef] 
[3] Drossman, D.A. and Hasler, W.L. (2016) Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology, 150, 1257-1261. [Google Scholar] [CrossRef] [PubMed]
[4] 申江红. 针刺治疗腹泻型肠易激综合征有效性与安全性研究[D]: [硕士学位论文]. 北京: 中国中医科学院, 2022.
[5] Black, C.J. and Ford, A.C. (2020) Global Burden of Irrita-ble Bowel Syndrome: Trends, Predictions and Risk Factors. Nature Reviews Gastroenterology & Hepatology, 17, 473-486. [Google Scholar] [CrossRef] [PubMed]
[6] Bouillon, R., Marcocci, C., Carmeliet, G., et al. (2019) Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocrine Reviews, 40, 1109-1151. [Google Scholar] [CrossRef] [PubMed]
[7] Wimalawansa, S.J., Razzaque, M.S. and Aldaghri, N.M. (2018) Calcium and Vitamin D in Human Health: Hype or Real? The Journal of Steroid Biochemistry and Molecular Bi-ology, 180, 4-14. [Google Scholar] [CrossRef] [PubMed]
[8] 谢忠建, 程群, 丁悦. 维生素D代谢和作用[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 26-33.
[9] Musazadeh, V., Zarezadeh, M., Ghalichi, F., et al. (2022) Vitamin D Supplementation Positively Affects Anthropometric Indices: Evidence Obtained from an Umbrella Meta-Analysis. Fron-tiers in Nutrition, 9, Article ID: 980749. [Google Scholar] [CrossRef] [PubMed]
[10] 中华医学会骨质疏松和骨矿盐疾病分会. 维生素D及其类似物临床应用共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(1): 1-19.
[11] Abbasnezhad, A., Amani, R., Ha-sanvand, A., et al. (2019) Association of Serum Vitamin D Concentration with Clinical Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome. Journal of the American College of Nutrition, 38, 327-333. [Google Scholar] [CrossRef] [PubMed]
[12] Meeker, S., Seamons, A., Maggio-Price, L., et al. (2016) Protective Links between Vitamin D, Inflammatory Bowel Disease and Colon Cancer. World Journal of Gastroenterol-ogy, 22, 933-948. [Google Scholar] [CrossRef] [PubMed]
[13] Silva, M.C. and Furlanetto, T.W. (2018) Intestinal Absorption of Vitamin D: A Systematic Review. Nutrition Reviews, 76, 60-76. [Google Scholar] [CrossRef] [PubMed]
[14] Assa, A., Vong, L., Pinnell, L.J., et al. (2014) Vitamin D Deficiency Promotes Epithelial Barrier Dysfunction and Intestinal Inflammation. The Journal of Infectious Diseases, 210, 1296-1305. [Google Scholar] [CrossRef] [PubMed]
[15] Dussik, C.M., Hockley, M., Grozic, A., et al. (2018) Gene Expression Profiling and Assessment of Vitamin D and Serotonin Pathway Variations in Patients with Irritable Bowel Syndrome. Journal of Neurogastroenterology and Motility, 24, 96-106. [Google Scholar] [CrossRef] [PubMed]
[16] Grozic, A., Coker, K., Dussik, C.M., et al. (2022) Identification of Putative Transcriptomic Biomarkers in Irritable Bowel Syndrome (IBS): Differential Gene Expression and Regulation of TPH1 and SERT by Vitamin D. PLOS ONE, 17, e0275683. [Google Scholar] [CrossRef] [PubMed]
[17] 付小梅, 陈秋月, 段光敏, 等. 微量元素、维生素在腹泻型肠易激综合征儿童中的水平及意义[J]. 中国妇幼健康研究, 2022, 33(7): 94-97.
[18] 黄思婧, 黄文森. 维生素D与肠易激综合征患者胃肠症状严重程度的相关性研究[J]. 右江民族医学院学报, 2019, 41(4): 387-390+395.
[19] Ford, A.C., Sperber, A.D., Corsetti, M., et al. (2020) Irritable Bowel Syndrome. The Lancet, 396, 1675-1688. [Google Scholar] [CrossRef] 
[20] Mishima, Y., Ishihara, S. (2020) Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome. International Journal of Molecular Sciences, 21, Article No. 8664. [Google Scholar] [CrossRef] [PubMed]
[21] Linsalata, M., Riezzo, G., D’attoma, B., et al. (2018) Nonin-vasive Biomarkers of Gut Barrier Function Identify Two Subtypes of Patients Suffering from Diarrhoea Predomi-nant-IBS: A Case-Control Study. BMC Gastroenterology, 18, Article No. 167. [Google Scholar] [CrossRef] [PubMed]
[22] Linsalata, M., Riezzo, G., Orlando, A., et al. (2021) The Rela-tionship between Low Serum Vitamin D Levels and Altered Intestinal Barrier Function in Patients with IBS Diarrhoea Undergoing a Long-Term Low-FODMAP Diet: Novel Observations from a Clinical Trial. Nutrients, 13, Article No. 1011. [Google Scholar] [CrossRef] [PubMed]
[23] Lobodesa, F.D., Backert, S., Nattramilarasu, P.K., et al. (2021) Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni. International Jour-nal of Molecular Sciences, 22, Article No. 8872. [Google Scholar] [CrossRef] [PubMed]
[24] 潘杰, 刘来浩, 牟建伟. 肠道菌群与人类健康研究进展[J]. 山东师范大学学报(自然科学版), 2021, 36(4): 337-365.
[25] Mei, L., Zhou, J., Su, Y., et al. (2021) Gut Microbiota Compo-sition and Functional Prediction in Diarrhea-Predominant Irritable Bowel Syndrome. BMC Gastroenterology, 21, Article No. 105. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, H.N., Wu, H., Chen, Y.Z., et al. (2017) Altered Molecular Signature of Intestinal Microbiota in Irritable Bowel Syndrome Patients Compared with Healthy Controls: A Systematic Review and Meta-Analysis. Digestive and Liver Disease, 49, 331-337. [Google Scholar] [CrossRef] [PubMed]
[27] Wei, W., Wang, H.F., Zhang, Y., et al. (2020) Altered Metabolism of Bile Acids Correlates with Clinical Parameters and the Gut Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome. World Journal of Gastroenterology, 26, 7153-7172. [Google Scholar] [CrossRef] [PubMed]
[28] Osadchiy, V., Martin, C.R. and Mayer, E.A. (2019) Gut Microbi-ome and Modulation of CNS Function. Comprehensive Physiology, 10, 57-72. [Google Scholar] [CrossRef] [PubMed]
[29] 余梦丽, 虞朝辉. 维生素D3/维生素D受体与炎症性肠病相关机制研究及临床应用[J]. 西南医科大学学报, 2022, 45(1): 7-12.
[30] Zhang, X.L., Chen, L., Yang, J., et al. (2023) Vita-min D Alleviates Non-Alcoholic Fatty Liver Disease via Restoring Gut Microbiota and Metabolism. Frontiers in Micro-biology, 14, Article ID: 1117644. [Google Scholar] [CrossRef] [PubMed]
[31] Spiller, R., Aziz, Q., Creed, F., et al. (2007) Guidelines on the Ir-ritable Bowel Syndrome: Mechanisms and Practical Management. Gut, 56, 1770-1798. [Google Scholar] [CrossRef] [PubMed]
[32] Moslemi, E., Musazadeh, V., Kavyani, Z., et al. (2022) Efficacy of Vitamin D Supplementation as an Adjunct Therapy for Improving Inflammatory and Oxidative Stress Biomarkers: An Umbrella Meta-Analysis. Pharmacological Research, 186, Article ID: 106484. [Google Scholar] [CrossRef] [PubMed]
[33] Garcia, P.M., Moore, J., Kahan, D., et al. (2020) Effects of Vita-min D Supplementation on Inflammation, Colonic Cell Kinetics, and Microbiota in Colitis: A Review. Molecules, 25, Ar-ticle No. 2300. [Google Scholar] [CrossRef] [PubMed]
[34] Sassi, F., Tamone, C. and D’amelio, P. (2018) Vitamin D: Nutri-ent, Hormone, and Immunomodulator. Nutrients, 10, Article No. 1656. [Google Scholar] [CrossRef] [PubMed]
[35] Jaime, J., Vargas-Bermudez, D.S., Yitbarek, A., et al. (2020) Differential Immunomodulatory Effect of Vitamin D (1,25(OH)2D3) on the Innate Immune Response in Different Types of Cells In-fected in Vitro with Infectious Bursal Disease Virus. Poultry Science, 99, 4265-4277. [Google Scholar] [CrossRef] [PubMed]
[36] Charoenngam, N. and Holick, F.M. (2020) Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients, 12, Article No. 2097. [Google Scholar] [CrossRef] [PubMed]
[37] Sprake, E.F., Grant, V.A. and Corfe, B.M. (2012) Vitamin D3 as a Novel Treatment for Irritable Bowel Syndrome: Single Case Leads to Critical Analysis of Patient-Centred Data. BMJ Case Re-ports, 2012, 223-227. [Google Scholar] [CrossRef] [PubMed]
[38] Abbasnezhad, A., Amani, R., Hajiani, E., et al. (2016) Effect of Vitamin D on Gastrointestinal Symptoms and Health-Related Quality of Life in Irritable Bowel Syndrome Patients: A Randomized Double-Blind Clinical Trial. Neurogastroenterology & Motility, 28, 1533-1544. [Google Scholar] [CrossRef] [PubMed]
[39] 姜莹, 李英仆. 维生素D改善肠易激综合征患者的临床症状和生活质量[J]. 西南军医, 2019, 21(2): 130-133.
[40] Mohamed, A., Shoaib, M., Mohamed, G., et al. (2022) The Effect of Vitamin D Supplementation on the Severity of Symptoms and the Quality of Life in Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 14, Article No. 2618. [Google Scholar] [CrossRef] [PubMed]
[41] Bouillon, R., Manousaki, D., Rosen, C., et al. (2021) The Health Effects of Vitamin D Supplementation: Evidence from Human Studies. Nature Reviews Endocrinology, 18, 96-110. [Google Scholar] [CrossRef] [PubMed]
[42] Holick, M.F., Binkley, N.C., Bischoff-Ferrari, H.A., et al. (2011) Evaluation, Treatment, and Prevention of Vitamin D Deficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 96, 1911-1930. [Google Scholar] [CrossRef] [PubMed]
[43] 张萌萌, 张秀珍, 邓伟民, 等. 骨代谢生化指标临床应用专家共识(2020) [J]. 中国骨质疏松杂志, 2020, 26(6): 781-796.

为你推荐